GLUCOCORTICOIDS INHIBIT ACCESSORY SIGNALS FOR T-CELL ACTIVATION VIA CD2

被引：0
|
作者：
PALLIOGIANNI, F [1 ]
BALOW, JE [1 ]
BOUMPAS, DT [1 ]
机构：
[1] NIH,BETHESDA,MD 20892
来源：
ARTHRITIS AND RHEUMATISM | 1993年 / 36卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S69 / S69
页数：1
相关论文
共 50 条
  • [31] SYNERGISTIC SIGNALING VIA THE T-CELL ANTIGEN RECEPTOR AND CD2 ANTIGEN
    SUTHANTHIRAN, M
    KIDNEY INTERNATIONAL, 1989, 35 (01) : 509 - 509
  • [32] DUAL FUNCTION OF RECOMBINANT HUMAN CD58 - INHIBITION OF T-CELL ADHESION AND ACTIVATION VIA THE CD2 PATHWAY
    ALBERTWOLF, M
    MEUER, SC
    WALLICH, R
    INTERNATIONAL IMMUNOLOGY, 1991, 3 (12) : 1335 - 1347
  • [33] REGULATION OF D-3 PHOSPHOINOSITIDES DURING T-CELL ACTIVATION VIA THE T-CELL ANTIGEN RECEPTOR CD3 COMPLEX AND CD2 ANTIGENS
    WARD, SG
    LEY, SC
    MACPHEE, C
    CANTRELL, DA
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (01) : 45 - 49
  • [34] DEFECTIVE CD2 PATHWAY T-CELL ACTIVATION IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    FOX, DA
    MILLARD, JA
    TREISMAN, J
    ZELDES, W
    BERGMAN, A
    DEPPER, J
    DUNNE, R
    MCCUNE, WJ
    ARTHRITIS AND RHEUMATISM, 1991, 34 (05): : 561 - 571
  • [35] A ROLE FOR IL-1 IN T-CELL ACTIVATION THROUGH THE CD2 PATHWAY
    WAKASUGI, H
    HUET, S
    MAHE, Y
    BERNARD, A
    TURSZ, T
    LYMPHOKINE RESEARCH, 1987, 6 (01): : U81 - U81
  • [36] DEFECTIVE CD2 T-CELL PATHWAY ACTIVATION IN COMMON VARIABLE IMMUNODEFICIENCY (CVID)
    ZIELEN, S
    DENGLER, TJ
    BAUSCHER, P
    MEUER, SC
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1994, 96 (02): : 253 - 259
  • [37] FUNCTIONAL-ANALYSIS OF CD2, CD4, AND CD8 IN T-CELL ACTIVATION
    BIERER, BE
    GREENSTEIN, JL
    SLECKMAN, B
    RATNOFSKY, S
    PETERSON, A
    SEED, B
    BURAKOFF, SJ
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1988, 532 : 199 - 206
  • [38] INDUCTION OF NUCLEAR CONTOUR IRREGULARITY DURING T-CELL ACTIVATION VIA THE T-CELL RECEPTOR CD3 COMPLEX AND CD2 ANTIGENS IN THE PRESENCE OF PHORBOL ESTERS
    REINHOLD, U
    HERPERTZ, M
    KUKEL, S
    OLTERMANN, I
    UERLICH, M
    KREYSEL, HW
    BLOOD, 1994, 83 (03) : 703 - 706
  • [39] DO CD2 AND CD3-TCR T-CELL ACTIVATION PATHWAYS FUNCTION INDEPENDENTLY
    KABELITZ, D
    IMMUNOLOGY TODAY, 1990, 11 (02): : 44 - 47
  • [40] CD48 IS A COUNTER-RECEPTOR FOR MOUSE CD2 AND IS INVOLVED IN T-CELL ACTIVATION
    KATO, K
    KOYANAGI, M
    OKADA, H
    TAKANASHI, T
    WONG, YW
    WILLIAMS, AF
    OKUMURA, K
    YAGITA, H
    JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05): : 1241 - 1249
12345